Home/Solutions/RWI for GP-led Secondaries
Product · 03

RWI requires judgment.
Not a product sheet.

Continuation vehicles don't fit the M&A RWI template. The named insureds are different, the reps are GP-level, and the retention mechanics have to flow per-LP. Placing a policy that actually covers what secondary LPs care about takes judgment built from the inside of the deals — not a submission form.

WolfTRI's compensation is the insurer-paid commission embedded in the carrier's premium. WolfTRI does not charge an additional retail broker fee.

Structure

How secondary RWI differs from M&A RWI.

Three structural differences matter. Miss them and the policy looks like M&A RWI on paper but doesn't cover the risks LPs actually care about.

01

Named insureds are secondary buyers

Not the CV itself. The secondary LPs are the direct policyholders — the parties whose capital is exposed to rep-level breach.

02

Reps are GP-level

Portfolio company condition, valuation methodology, conflicts disclosure, fund document integrity — not target-company operating reps.

03

Retention is per-LP not per-tower

Structured so each secondary buyer has a retention proportionate to commitment. Not a single pooled deductible the largest LP absorbs.

Vehicle types

Continuation structures we place on.

Market is bifurcated: single-asset CVs and multi-asset CVs have different carrier appetites and different rep structures.

Single-asset CV

One portfolio company, extended hold

Most common GP-led structure. RWI wraps the GP's reps on that single asset's condition, financials, pipeline, and material contracts. Placement turns on QofE quality and advisor confirmation of valuation.

$25M–$300M limits2.5–3.5% ROL
Multi-asset CV

Strip sales & tail-end portfolios

Multiple portfolio companies moved into a continuation vehicle. Reps are structured at portfolio level with asset-by-asset disclosure schedules. Underwriting is more complex; carrier appetite is narrower.

$50M–$500M limits2.8–4.0% ROL
Tender offer

LP liquidity facilitation

Existing LP offered liquidity at GP-negotiated price. RWI less common here but increasingly discussed where price protection on valuation is at issue. Specialist structure.

Deal-specificDeal-specific
Key reps covered

The GP-level reps the policy protects.

These are the rep categories that secondary LPs most often negotiate — and that the RWI policy must cover for the structure to be viable.

01

Portfolio condition

Accuracy of portfolio company financials, pipeline, operating metrics, and valuation methodology as of transfer.

02

Conflicts clearance

Compliance with fund document conflicts provisions, LPAC approval procedures, and fiduciary obligations to transferring LPs.

03

Material contracts

Integrity of key portfolio company contracts, customer concentration, and no undisclosed changes in control triggers.

04

Regulatory & compliance

Adviser regulatory compliance where applicable, ERISA compliance where applicable, fund document compliance, AML/KYC program integrity.

Timeline

How the placement runs alongside the CV process.

Secondary placements are often time-constrained by the secondary investor's fund-cycle timing. WolfTRI builds the RWI process to close with the vehicle — not after it.

01

LPAC discussion

WolfTRI's licensed producer joins secondary advisor calls early to establish RWI as a feasible structure. Sets the negotiation floor for indemnity terms.

02

Submission & NBIs

Once secondary term sheet is signed, WolfTRI's licensed producer submits to 3–4 carriers with secondaries appetite. NBIs within 7–10 days.

03

UW & conflicts diligence

Joint call with secondary counsel, fund counsel, and carrier UW. Conflicts clearance process reviewed in detail.

04

Bound at vehicle close

WolfTRI's licensed producer aligns binder delivery with the CV closing date; inception terms reflect the negotiated policy form.

GP-led continuation structure, with coverage that matches.

WolfTRI works with secondary advisors, GP counsel, and fund counsel to align the policy with the transaction.